IP and Legal Filings

MAY 10, 2024

Its gained momentum with the advent of importance in R&D and patent registration. It’s the first important step towards protecting owner’s rights and its lawful public use. If IPR is not understood in technology transfer process, sharing of knowledge and invention faces legal challenges. It helps in better valuation.

Intellectual Property 100

Intellectual Property Technology Licensing Invention 100

LexBlog IP

OCTOBER 24, 2022

Under typical Phase 1 contracts with the Department of Defense (DoD), such as the Air Force Research Lab (AFRL), default ownership of domestic and international intellectual property rights belong to the Contractor. The nations in which the Contractor seeks to file the patent application. media screen and (max-width: 1023px) {.thegem-vc-text.thegem-custom-63579507143ea2268{display:

Intellectual Property 52

Intellectual Property Invention Contracts Patent Application 52

The IPKat

DECEMBER 22, 2023

PatKat reviewing the year It is time once more for the IPKat patent year in review! Another source of confusion is the divergent approaches of the UK courts and the EPO with respect to the test for the evidence standard in sufficiency and inventive step analysis. Food for thought. This is one to watch for 2024.

Invention 110

Invention Inventor Patent Law 110

LexBlog IP

JANUARY 5, 2022

26 , rejected the claim that taking away, or ignoring, the ability-to-control indicia of ownership amounts to a taking: Similarly, property rights, including copyright, have been described as ownership of a bundle of rights or interests. 92, 96 (1876) (“A patent for an invention is as much property as a patent for land.

Intellectual Property 52

Intellectual Property Government Invention Copyright 52

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

Manufacturers of Enbrel ® biosimilars (Sandoz and Samsung Bioepis) have been embroiled in patent litigation with Immunex, and, as discussed below, Sandoz recently lost its appeal to the Federal Circuit. All currently approved Humira ® biosimilars cannot launch until 2023 per settlements with AbbVie. FDA Addresses the COVID-19 Global Pandemic.

Settlement 52

Settlement Litigation Marketing Marketing 52

SpicyIP

JANUARY 5, 2024

It seems that the domestic pressure resulting from their ever-increasing healthcare costs has reached a point where there is finally some re-examination of how their patent system is affecting costs. According to the NIST, the US govt invests approximately $115 billion in R&D through various universities, non-profits, and businesses.

Invention 69

Invention Government Intellectual Property IP 69